These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37438104)
1. Impact of qualifying artery on the efficacy of stenting plus medical therapy versus medical therapy alone in patients with symptomatic intracranial stenosis: a post-hoc analysis of the CASSISS trial. Wu Q; Wang J; Zheng B; Qi J; Xu S; Wu P; Zhang G; Ji Z; Wang C; Yao J; Jiao L; Gao P; Wang T; Wang D; Li T; He Y; Zhao Z; Cai Y; Wu W; He W; Shi H; Li Y; J Neurointerv Surg; 2024 Jun; 16(7):663-669. PubMed ID: 37438104 [TBL] [Abstract][Full Text] [Related]
2. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial. Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L; JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472 [TBL] [Abstract][Full Text] [Related]
3. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis? Lutsep HL; Lynn MJ; Cotsonis GA; Derdeyn CP; Turan TN; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI; Stroke; 2015 Nov; 46(11):3282-4. PubMed ID: 26382173 [TBL] [Abstract][Full Text] [Related]
4. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ; Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089 [TBL] [Abstract][Full Text] [Related]
5. Vertebral artery stenting to prevent recurrent stroke in symptomatic vertebral artery stenosis: the VIST RCT. Markus HS; Larsson SC; Dennis J; Kuker W; Schulz UG; Ford I; Clifton A; Rothwell PM Health Technol Assess; 2019 Aug; 23(41):1-30. PubMed ID: 31422789 [TBL] [Abstract][Full Text] [Related]
6. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China. Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656 [TBL] [Abstract][Full Text] [Related]
7. Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis: The BASIS Randomized Clinical Trial. Sun X; Deng Y; Zhang Y; Yang M; Sun D; Nguyen TN; Tong X; Peng G; Liu A; Xu Y; Wu Y; Geng X; Wang Y; Li T; Xing S; Wu W; Ji Y; Yang H; Wang S; Gao X; Yang W; Zhao X; Liu L; Ma N; Gao F; Mo D; Huo X; Song L; Li X; Zhang J; He H; Lv M; Mu S; Yu W; Liebeskind DS; Amin-Hanjani S; Wang Y; Wang Y; Miao Z; JAMA; 2024 Oct; 332(13):1059-1069. PubMed ID: 39235816 [TBL] [Abstract][Full Text] [Related]
8. Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study. Ma N; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Mo D; Gao F; Wang Y; Wang Y; Feng L; Miao Z Stroke Vasc Neurol; 2018 Sep; 3(3):176-184. PubMed ID: 30294474 [TBL] [Abstract][Full Text] [Related]
9. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ; Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis. Xu R; Zhang X; Liu S; Wang X; Wang W; Yang K; Wang T; Dmytriw AA; Bai X; Ma Y; Jiao L; Yang B Cochrane Database Syst Rev; 2022 May; 5(5):CD013692. PubMed ID: 35579383 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Coward LJ; McCabe DJ; Ederle J; Featherstone RL; Clifton A; Brown MM; Stroke; 2007 May; 38(5):1526-30. PubMed ID: 17395869 [TBL] [Abstract][Full Text] [Related]
12. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial. Markus HS; Larsson SC; Kuker W; Schulz UG; Ford I; Rothwell PM; Clifton A; Neurology; 2017 Sep; 89(12):1229-1236. PubMed ID: 28835400 [TBL] [Abstract][Full Text] [Related]
13. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. Zaidat OO; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Megerian JT; Lesko J; Pitzer P; Ramos J; Castonguay AC; Barnwell S; Smith WS; Gress DR; JAMA; 2015 Mar 24-31; 313(12):1240-8. PubMed ID: 25803346 [TBL] [Abstract][Full Text] [Related]
14. Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. Markus HS; Harshfield EL; Compter A; Kuker W; Kappelle LJ; Clifton A; van der Worp HB; Rothwell P; Algra A; Lancet Neurol; 2019 Jul; 18(7):666-673. PubMed ID: 31130429 [TBL] [Abstract][Full Text] [Related]
15. Stenting versus aggressive medical therapy for intracranial arterial stenosis: more harm than good. Al Hasan M; Murugan R Crit Care; 2012 May; 16(3):310. PubMed ID: 22574950 [TBL] [Abstract][Full Text] [Related]
16. Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis : Perspective for future clinical trials. Maier IL; Karch A; Lipke C; Behme D; Mpotsaris A; Kabbasch C; Liebig T; Faymonville A; Reich A; Nikoubashman O; Buhk JH; von Schoenfeld P; Weber W; Mikolajczyk RT; Bähr M; Knauth M; Kallenberg K; Liman J Clin Neuroradiol; 2018 Mar; 28(1):33-38. PubMed ID: 27506672 [TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. Waters MF; Hoh BL; Lynn MJ; Kwon HM; Turan TN; Derdeyn CP; Fiorella D; Khanna A; Sheehan TO; Lane BF; Janis S; Montgomery J; Chimowitz MI; JAMA Neurol; 2016 Mar; 73(3):308-15. PubMed ID: 26747792 [TBL] [Abstract][Full Text] [Related]
18. Stenting for symptomatic intracranial vertebrobasilar artery stenosis: 30-day results in a high-volume stroke center. Liu L; Zhao X; Mo D; Ma N; Gao F; Miao Z Clin Neurol Neurosurg; 2016 Apr; 143():132-8. PubMed ID: 26943722 [TBL] [Abstract][Full Text] [Related]
19. Stenting of symptomatic basilar and vertebral artery stenosis in patients resistant to optimal medical prevention: the lyon stroke unit experience. Ralea IC; Nighoghossian N; Tahon F; Derex L; Cakmak S; Trouillas P; Turjman F Eur Neurol; 2008; 60(3):127-31. PubMed ID: 18628630 [TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with major cerebrovascular complications after intracranial stenting. Nahab F; Lynn MJ; Kasner SE; Alexander MJ; Klucznik R; Zaidat OO; Chaloupka J; Lutsep H; Barnwell S; Mawad M; Lane B; Chimowitz MI; Neurology; 2009 Jun; 72(23):2014-9. PubMed ID: 19299309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]